Back
Aurinia Pharmaceuticals Stock Price Chart
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Buy
52
AUPH
Aurinia Pharmaceuticals
Last Price:
5.06
Seasonality Move:
3.33%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight buying pressure.
Aurinia Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.14 | Buy |
| 20-day SMA: | 5.05 | Buy |
| 50-day SMA: | 5.15 | Buy |
| 200-day SMA: | 7.61 | Sell |
| 8-day EMA: | 5.13 | Buy |
| 20-day EMA: | 5.1 | Buy |
| 50-day EMA: | 5.43 | Sell |
| 200-day EMA: | 7.18 | Sell |
Aurinia Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 51.93 | Buy |
| Chaikin Money Flow: | 219902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.95 - 5.15) | Buy |
| Bollinger Bands (100): | (4.94 - 8.12) | Sell |
Aurinia Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 5.17 while AUPH 8-day simple moving average is 5.14, which is a Buy signal.
- The stock price of AUPH is 5.17 while Aurinia Pharmaceuticals 20-day SMA is 5.05, which makes it a Buy.
- Aurinia Pharmaceuticals 50-day simple moving average is 5.15 while AUPH share price is 5.17, making it a Buy technically.
- AUPH stock price is 5.17 and Aurinia Pharmaceuticals 200-day simple moving average is 7.61, creating a Sell signal.
AUPH Technical Analysis vs Fundamental Analysis
Buy
52
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a Buy
The current Aurinia Pharmaceuticals [AUPH] share price is $5.17. The Score for AUPH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
739.77M
Price in USD:
5.17
Share Volume:
691.12K
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
12.43
52-Week Low:
4.71
Buy
52
Aurinia Pharmaceuticals (AUPH)
is a Buy
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?
The Aurinia Pharmaceuticals stock price is 5.17 USD today. -
Will AUPH stock go up or go down?
Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Aurinia Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is not overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 5.17 while AUPH 8-day exponential moving average is 5.13, which is a Buy signal.
- The stock price of AUPH is 5.17 while Aurinia Pharmaceuticals 20-day EMA is 5.10, which makes it a Buy.
- Aurinia Pharmaceuticals 50-day exponential moving average is 5.43 while AUPH share price is 5.17, making it a Sell technically.
- AUPH stock price is 5.17 and Aurinia Pharmaceuticals 200-day simple moving average is 7.18, creating a Sell signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
- AUPH Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Aurinia Pharmaceuticals is a Sell
- Aurinia Pharmaceuticals Relative Strength Index (RSI) is 51.93, which suggest Aurinia Pharmaceuticals is overbought
- The Bollinger Bands (25) for Aurinia Pharmaceuticals is (4.95 - 5.15), which suggest Aurinia Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Aurinia Pharmaceuticals is (4.94 - 8.12), which suggest Aurinia Pharmaceuticals is a Sell
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.